EU AI Act compliance, pharmaceutical inventory AI, data sovereignty, and supply chain best practices — written for mid-market pharma operations teams.
Excess inventory, spreadsheet-only forecasting, supplier blind spots, compliance bottlenecks, and competitors already ahead — the five signals that mid-market pharma manufacturers need AI supply chain intelligence now.
High-risk AI systems in pharmaceutical manufacturing face mandatory compliance by August 2, 2026. Here's what the regulation actually requires — and why mid-market pharma manufacturers are most exposed.
15-point checklist used by 200+ pharma operations teams — covers high-risk AI system requirements, documentation, and audit trails.
Book a 30-minute demo and see how Watchdogs AI handles your supply chain.